Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Scand J Rheumatol ; 50(6): 417-426, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33775211

RESUMO

Objectives: Previous studies of high-resolution peripheral quantitative computed tomography (HR-pQCT) imaging of hand joints in patients with rheumatoid arthritis (RA) have suggested that erosion healing may occur. Our objective was to examine changes in erosion volume, joint space width (JSW), bone mineral density (BMD), and bone remodelling, and their association with clinical outcomes and measures of patient hand function.Method: We examined 48 patients who achieved a good response to a newly initiated biologic therapy. HR-pQCT images of the dominant hands' second and third metacarpophalangeal joints were obtained 3 and 12 months after therapy initiation. Bone erosion volume, JSW, BMD, and bone remodelling were quantified from HR-pQCT images, with improvement, no change (unchanged), or progression in these measures determined by least significant change. Disease activity and hand function measures were collected.Results: There were no significant group changes in HR-pQCT outcomes over the 9 month period. Twenty-two patients had total erosion volumes that remained unchanged, nine showed improvement, and two progressed. The majority of JSW and BMD measures remained unchanged. There was a significant association between the baseline Health Assessment Questionnaire score and the change in minimum JSW, but no other significant associations between HR-pQCT outcomes and function were observed.Conclusions: The vast majority of patients maintained unchanged JSW and BMD over the course of follow-up. Significant improvements in total erosion volume occurred in 27% of patients, suggesting that biologic therapies may lead to erosion healing in some patients, although this did not have an impact on self-reported and demonstrated hand function.


Assuntos
Antirreumáticos , Artrite Reumatoide , Produtos Biológicos , Terapia Biológica , Antirreumáticos/farmacologia , Artrite Reumatoide/diagnóstico por imagem , Artrite Reumatoide/tratamento farmacológico , Produtos Biológicos/farmacologia , Densidade Óssea/efeitos dos fármacos , Densidade Óssea/fisiologia , Humanos , Articulação Metacarpofalângica/efeitos dos fármacos , Articulação Metacarpofalângica/fisiologia , Resultado do Tratamento
4.
Head Neck Surg ; 7(6): 479-83, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-4044268

RESUMO

A case of soft tissue myxoma in scalp is reported in a patient with a history of congenital cleft lip and palate. Review of the literature shows head and neck soft tissue myxoma occurs almost in every decade of life with peak occurrence in the fourth decade. Men are affected more than women. The most common location in the head and neck region is the palate, followed by the parotid area. The prognosis of this soft tissue tumor is good. Conservative surgical excision with adequate margins is the treatment of choice. Several theories concerning the pathogenesis of this tumor are discussed, with the theory that a basic error in tissue metabolism during initial growth is the most compatible to the elements of this case. Differential diagnosis regarding this type of lesion is also discussed.


Assuntos
Mixoma/patologia , Couro Cabeludo , Neoplasias Cutâneas/patologia , Diagnóstico Diferencial , Humanos , Masculino , Pessoa de Meia-Idade , Mixoma/diagnóstico , Mixoma/cirurgia , Couro Cabeludo/patologia , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/cirurgia , Neoplasias de Tecidos Moles/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...